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ABSTRACT 
Consumption of fruits and vegetables fight against oxidative damage by inhibiting or reducing free radicals and reactive oxygen species. Mimosa 
pudica is a perennial herb and belongs to the family Fabaceae. Epidemiological studies have shown that M. pudica contains metabolites such as 
phenols and flavonoid compounds which possess pharmacological properties such as antidiabetic, antimicrobial, antiulcer, antidepressants and 
anti-inflammatory. Ecological studies have shown that M. pudica grows in all types of soil which can survive in soil with low nutrient concentration. 
It usually requires disturbed soil to establish itself. It is commonly seen in the wastelands and along roadsides, which is an ethnomedical plant that 
may be used in managing various types of disease. Valuable information and literature on M. pudica are analysed and consulted using a different 
database such as Google Scholar, Google, Science Direct, Web of Science, Academic Journals and Pubmed. This review article summarises the 
pharmacological properties of M. pudica. 
Keywords: Mimosa pudica, Reactive oxygen species, Anti-diabetic, Anti-inflammatory, Antimicrobial 




Consumption of fruits and vegetables fight against oxidative damage 
by inhibiting or reducing free radicals and reactive oxygen species 
(ROS) [1, 2]. Many plants including vegetables and fruits contain 
natural antioxidants that can combat oxidative stress and play a 
crucial part in the chemoprevention of diseases that have their 
aetiology and pathophysiology in ROS [3, 4]. These properties are 
believed to be attributed to the antioxidants like flavonoids, 
lycopene, carotenoids, β-carotene and phenolic compounds. Herbs 
have been a source of medicinal agents for centuries and are an 
excellent source of nutraceuticals. Herbal therapy is mainly used to 
treat cardiovascular problems, liver disorders, central nervous 
system, digestive and metabolic disorders [1, 5]. Researchers are 
currently focusing on the medicinal properties of plant products 
with bio-active potentials which have good therapeutic 
characteristics. Recent studies have been focused on the 
pharmacological actions of M. pudica (fig. 1) which have effective 
anti-diabetic, antitoxin, antihepatotoxic, antioxidant activities [4, 5].  
M. pudica, also known as Lajjalu in Ayurveda, is widely used as an 
antidepressant and anti-asthmatic in the treatment of various kind 
of ailments [6, 7]. Epidemiological studies have also shown that M. 
pudica contains metabolites such as phenols and flavonoid 
compounds which possess anticancer and antidiabetic properties 
[8]. Research also has been demonstrated that different parts of this 
plant are widely used in the treatment of multiple diseases [9, 10]. 
This article focusses on the pharmacological and traditional 
properties of M. pudica [11, 12]. 
Ecology 
M. pudica grows in all types of soil; it can survive in soil with low 
nutrient concentration. It usually requires disturbed soil to establish 
itself. Frequent burning may encourage its spread in pastures. The 
plant does shade sensitive and does not grow under forest canopies. 
Carbon disulfide is produced by the root which discerning inhibit 
colonization of the rhizosphere by mycorrhizal and pathogenic fungi. 
This plant grows by the roadsides or area disturbed by 
constructions; it usually grows as a single plant or in tangled 
thickets. It also grows near sea level up to 1,300m in elevation with 
annual precipitations from about 1000 to 200 mm [12, 13]. 
 
Fig. 1: Mimosa pudica [5] 
 
Constituents 
M. pudica stem and root tend to contain alkaloids the adrenaline-like 
substance has been identified in the leaves. The roots of the plant are 
also said to contain tannins, and the seeds’ mucilage is composed of 
D-xylose and d-glucuronic acid [14]. The chromatographic 
procedure revealed that petroleum fraction contains mainly amino 
acids, phytosterol, flavonoids, and alkaloids. The essential oils and 
fatty acid are present in the benzene extracts, and the chloroform 
extracts showed the presence of alkaloids [15]. The chemical 
constituents of M. pudica [15] are listed in table 1 and fig. 2. 
Bending movement of M. pudica 
M. pudica is said to have a unique motor organ which can either be 
pulvini or epinastic. Both processes involve the increase in the rate 
of membrane water transport which is facilitated by aquaporin 
which has been shown in many cases. Tonoplast and plasma 
membrane help in localizing aquaporins to seismonastic leaf 
movement in M. pudica and has been analysed [16]. The bending 
movement of M. pudica pulvinus causes a rapid change in volume of 
the abaxial motor cell in response to various environmental stimuli. 
The bending movement of M. pudica is delayed by treatment with 
actin affecting reagent and calcium channels inhibitors. The filament 
International Journal of Pharmacy and Pharmaceutical Sciences 
ISSN- 0975-1491                 Vol 11, Issue 3, 2019 
Hassan et al. 
Int J Pharm Pharm Sci, Vol 11, Issue 3, 12-16 
 
13 
of actin found in motor cells is a fragment in response to electrical 
stimulation. The study has shown that increased in levels of calcium 
is due to the depolymerization of the actin cytoskeleton in pulvinus 
motor cells in response to the electrical signals [17]. 
  
Table 1: Chemical constituent of M. pudica 
Parts Chemical constituents 
Stem Mimosine, 5-MeO-DMT (2), β-[N-(3-hydroxypyridone-4)]-α-aminopropionic acid. 
Root Mimosine, alkaloids, amino acids, glycoside, fatty acid, flavonoid, phytosterol and tannins. crocetin, ascorbic acid, D-glucuronic acid, 
linoleic acid, D-xylose and B-sitosterols 
Leaves Tyrosin, vitexin, nor-epinephrine, d-pinitol, b-sitosterol, alkaloids-mimosine, terpenoids, flavonoids, glycosides, alkaloids, phenols, 
tannins, saponins, and coumarins, polyunsaturated fatty acid, sphingosine, adrenalin, 5-MeO-DMT (2), 5,7,3’,4’-tetrahydroxy-6-C-[B-D-


































Fig. 2: Structure of different types of M. pudica phytoconstituents [15] 
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Traditional uses of M. pudica 
The root of M. pudica is declared to be bitter, cooling vulnerary, 
acrid, alexipharmic and used in the treatment of various types of 
diseases such as leprosy, dysentery, inflammation and many more 
by Ayurveda [12, 13]. The Unani Healthcare system uses its root in 
the treatment of disease arising from blood impurities and bile, 
bilious fevers, piles and jaundice. It also reduces a toothache by the 
decoction of root with water. It is also found to arrest bleeding and 
fasten the wound healing process. It is also used in herbal 
preparation for a gynaecological disorder [13]. It is beneficial in the 
treatment of diarrhoea, amoebic dysentery and has been researched to 
have medicinal properties to cure skin diseases. Studies have shown 
that it is also used to treat neurological problems [18]. The flower, 
root, stem, leave, and the fruits are used as medicines in the traditional 
health care system different parts of the plants are used in India for 
long for treatment of various kind of ailments. Researchers have 
indicated that M. pudica is used to relax the mind, relieves depression, 
mental distress, irritability and amnesia. It is also used to enhance 
mood and improves the circulation of blood. It also promotes healthy 
cell growth and prevents baldness. In western medicine, its root was 
used for the treatment of insomnia, irritability, premenstrual 
syndrome haemorrhoids and whooping cough [19].  
Pharmacological effects 
Anti-helminthic activity 
Helminths have been a foremost degenerative disease disturbing 
large percentage of the world and pose an enormous threat to public 
health in the developing countries which contribute to various 
ailments such as malnutrition, anaemia, eosinophilia and 
pneumonia. The parasite of helminths mainly subsists in the human 
body in the intestinal tract. Resistance in helminths against 
conventional anthelmintics is a leading problem in the treatment of 
the diseases. M. pudica has been reported to have anti-helminths 
activity. Another study by Pratap et al. shows the anti-helminthic 
activity of aqueous leaves extracts of M. pudica. Albendazole was 
used as a standard drug, prepared in four different concentration of 
20, 40, 60 and 80 mg/ml which was further dissolved in normal 
saline. The earthworm P. posthuman was divided into five groups 
consisting of two equal sizes and then released into 30 ml of the 
experimental formulations. Freshly prepared a standard drug and 
Aqueous extracts of M. pudica was used for the experiment. The 
paralysis time was recorded when there were no movements 
observed, and death time was recorded in minutes. The aqueous 
extracts showed considerable anti-helminthic activity which varies 
with different concentration [20, 21]. 
Antihepatotoxic activity 
Research has shown that the leaves of M. pudica possess 
hepatoprotective activity, in a study conducted involving 14 d 
administration of ethanolic leave extracts to Wistar rats treated with 
carbon tetrachloride at a dose of 200 mg/kg p. o. This study also 
shows that a high level of serum SGPT, SGOT, ALP and total bilirubin, 
due to CCL4 (carbon tetrachloride) treatment, were found to be 
restored close to normal on therapy with M. pudica. The study 
revealed the hepatoprotective effects of M. pudica due to antioxidant 
properties. Another research by Ayan et al. evaluated the 
hepatoprotective activity of ethanolic leave extracts of M. pudica. 
Wister rats of both sexes were used weighing between 150-200g, 
the animals were acclimatised under standard laboratory protocols. 
Carbon tetrachloride was used to induce liver toxicity in the 
experimental rats subcutaneously at a dose of 1 ml/kg b. w for one 
week. The animals were divided into five groups of six animal, and 
Silymarin was used as a standard which was administered for one 
week at a dose of 100 mg/kg p. o. M. pudica was administered to a 
different group at a dose of 400 mg/kg p. o for one week. Blood was 
collected at the end of the experiment, and biochemical parameters 
were estimated such as Total Bilirubin (TB), Direct Bilirubin (DB), 
Alkaline Phosphatase (ALP), Serum Glutamate Pyruvate 
Transaminase (SGPT) and Serum glutamate oxaloacetate 
transaminase (SGPT). The results of the CCL4 induced hepatotoxicity 
were estimated, and the group which received ethanolic leave 
extracts of M. pudica at a dose of 400 mg/kg and the standard drug 
Silymarin showed a significant decrease in the elevated levels of 
SGPT, SGOT, ALP, TB, and DB. This study shows the hepatoprotective 
effects of M. pudica [22, 23] 
Wound healing activity 
Damage in living tissue caused by a cut, blow, or other impacts is 
termed as a wound. M. pudica chloroform extract possess wound 
healing activity at a dose of 200 mg/kg in 5% ointment of the leaf 
extracts. Wound healing is a natural process initiated by trauma and 
often terminated by scar formation; the wound healing activity was 
reported to be performed by using excision and incision wound 
models [10]. Different studies have also shown that both methanolic 
and aqueous extracts of M. pudica in simple ointment base at a 
different concentration of 0.5%(w/w), 1%(w/w) and 2%(w/w) 
possess wound healing activity. Three different types of models in 
rats were used, which are excision, incision and estimation of 
biochemical parameters. The 2%(w/w) methanolic and aqueous 
extracts exhibited significant wound healing activity probably due to 
phenols constituent in M. pudica. Another research by Ganesh et al. 
shows the wound healing activity of M. pudica ethanolic extracts. Mice 
were used for this study and were acclimatized according to standard 
laboratory protocols. Different doses of M. pudica 50, 100, 150 and 200 
mg/kg b. wt were administered to the animals for six weeks before the 
creation of deep dermal excision wound. At the end of the experiment 
the administration of M. pudica extracts of different concentration 
increased the wound contraction in a dose-dependent manner, and 
also reduction in wound healing time [24, 25]. 
Antifertility activity 
M. pudica has been used in India for treatment of a different kind of 
ailment but is commonly used as an antifertility agent. The methanol 
extract of the root was administered orally to Swiss albino mice for 
twenty-one consecutive days. Phytochemical studies of the extract 
were carried out using thin layer chromatography (TLC) and 
quantitative methods [11]. Hormones responsible for reproduction 
(such as luteinizing hormone (LH), follicle-stimulating hormone (FSH), 
prolactin, estradiol, progesterone), oestrous cycle and many litters 
produced were studied in both extracts administered and control 
groups by using standard methods. The decrease in FSH levels in the 
pro-oestrous and oestrous stage in the extract administered group 
compared with those of the control animals indicates the disturbance 
of the oestrous cycle and ovulation through suppression of FSH. This 
study suggested that the root of M. pudica may possess antifertility 
effects as it disturbs the secretion of gonadotropin hormone and it 
prolongs the oestrous cycle in albino mice [10]. 
Antidepressants 
The rate of prevalence of mental disorder patients was observed to 
be around 65.4/1000 population. Out of which prevalence rate for 
the affective disorder is estimated to be 31.2/1000 populations. 
Antidepressants widely prescribed for depression, have significant 
limitations which include long time lag for therapeutic response and 
low response rates, which problematic for disease associated with a 
high rate of suicide [26]. The aqueous extract of M. pudica is 
employed to reduce depression in Mexico. This study showed the 
behavioural actions of M. pudica extract at different concentration 
was tested. Rats having received several dosages of aqueous extracts 
from M. pudica (2.0 mg/kg; 4.0 mg/kg; 6.0 mg/kg 8.0 mg/kg) or 
received normal saline (0.9% 0.30 ml; J. P.) clomipramine, and 
desipramine for 30days, after which were subjected to forced 
swimming test and the test for differential reinforcement of low 
rates response at 72 second. M. pudica of different doses responsible 
for any possible anxiolytic action were compared with those caused 
by diazepam (1.3 mg/kg J. P) in the elevated plus maze test. Results 
showed that M. pudica extracts, clomipramine, desipramine reduced 
immobility in the forced swimming test and increased the rate of 
reinforcers received in the DRL-72s test, the results show that M. 
pudica produces antidepressant effects in rats [27, 28]. 
Anxiolytic agent 
Anxiety is usually accompanied by nervous behaviour, which is an 
emotion categorised by an unpleasant state of inner turmoil. Anxiety 
is associated with muscular tension, fatigue, restlessness and 
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problems in concentrations. Individuals may suffer from anxiety 
disorder when experienced regularly. Anxiety can be a long-term 
trait or short-term state [29, 30]. M. pudica plant was used in 
traditional medicine in some developing countries such as 
Cameroon to treat anxiety disorders [31]. Anxiety disorders have 
severe impacts on life. Rats were used for the experiment which the 
anxiolytic activity was found in the animals when the EPM (elevated 
plus maze) was conducted and has shown that M. pudica reduces the 
percentage of closed arm entries and increases the number of 
entries into the percentage of entries and time in the open arms. The 
correlation of the increase in time spent in open arm with the rise in 
the number of entries supported the anxiolytic activity of the plant. 
It could be due to the presence of some components in the plant 
extracts interaction with GABA (Gamma-aminobutyric acid) 
receptors as an antagonist [32]. 
Hypolipidemic activity 
Researches have utilised hat high-fat diet induced on rats’ models to 
study the hypolipidemic action of M. pudica. Reports have shown 
that hyperlipidemia in experimental rats demonstrated an 
improvement in the levels of triglycerides, LDL, VLDL and 
cholesterol. The ethanolic extracts of M. pudica showed the 
significant hypolipidemic effect by lowering the serum of the 
biochemical param with a substantial reduction in the level of 
triglycerides, LDL, VLDL and cholesterol and increase in HDL level 
which was similar to the drug used as the control (lovastatin). The 
preliminary phytochemical of these studies show the presence of 
phytoconstituent such as steroid, flavonoids, glycoside alkaloids and 
phenolic compounds [33]. Another report by Piyapong and Ampa 
shows the hypolipidemic activity of M. pudica extracts. Albino rats 
weighing 150-200g were used and acclimatised according to 
standard laboratory protocols. The rats were divided into six groups 
each containing eight rats; Streptozotocin was used to induce 
diabetes to the animal through single intraperitoneal injection at a 
dose of 65 mg/kg. bw. The experiment lasted for eight weeks, blood 
serum was collected, and biochemical parameters were analysed. 
The group which received M. pudica extracts tend to have a high 
level of HDL and TG, TC and LDL decrease which shows the 
hypolipidemic potential of M. pudica [34]. 
Antivenom activity  
Lethality of Najakauthia venom tends to be neutralised by 
polyphenols found in M. pudica such as tannins. Survival of mice 
after 24 h was maintained when M. pudica tannins were 
preincubated with N. kaouthia venom. The group in which there was 
no preincubation, no protection against the effect of the toxin was 
observed. Commercial tannic acid was found to have lower efficiency 
as compared to the tannins from M. pudica in neutralising the 
lethality of N. kaouthia venom. Two protein spots were missing in 
the two-dimensional gel electrophoresis of the MTP treated animal 
indicating the down-regulation of the venom proteins. The result 
from this study shows that M. pudica has a better effect in 
neutralising the venom from N. kaouthia than commercial tannic 
acid in vitro. However, further research needs to establish that. 
pudica has a potential for treating N. kaouthia snakebites [35]. 
Antiulcer activity 
Three different types of solvent (90% methanol, chloroform and 
diethyl ether) was used for this extraction. Albino rats were used to 
investigate the antiulcer activity and was induced with alcohol and 
aspirin. The parameters obtained from this study shows that M. 
pudica has anti-ulcer properties. One hundred and 200 mg/kg dose 
levels of the extract and 20 mg/kg of the standard drug Ranitidine 
was used orally. Toxicity studies were done which they found out 
that the extract is safe up to a concentration of 2000 mg/kg body 
weight and 100 mg which shown good activity [36, 37]. 
Antiinflammatory activity 
The anti-inflammatory activity of M. pudica was investigated using 
male albino rats. Three different extracts of M. pudica was used, 
which are petroleum ether, ethanol and aqueous extracts. The model 
of the rats used was carrageenan-induced paw oedema and cotton 
pellet granuloma in rats. Different doses, 50, 100 and 200 mg/kg, of 
extracts, were used, and indomethacin, administered orally, was 
used as a standard at a concentration of 10 mg/kg Carrageenan-
induced rat paw oedema was used for evaluating the reduction of 
oedema induced by carrageenan [38]. Another study by Nair and 
Bindu also investigated the anti-anti-inflammatory effect of the 
whole plant of M. pudica, in thirty albino rats of both sexes was used 
for the experiment. Two hundred (200) mg/kg, 400 mg/kg and 800 
mg/kg extracts of M. puidca was administered to three different 
groups, 800 mg/kg concentration has the highest percentage 
inhibition. The result from this recent study also shows that M. 
pudica has anti-inflammatory properties [39]. 
Antidiabetic activity 
Diabetes is a metabolic disorder which affects people of all age, most 
prominent in middle age and old aged people. Various complications 
have been associated with diabetes such as obesity, renal 
dysfunction and blood lipid abnormalities. Patient self–management 
education and continued medical care are required to prevent acute 
complication and longtime effects. Anti-diabetic effect of M. pudica 
was investigated using male albino rats weighing between 150-
200g, ethanolic extracts of M. pudica was administered at a dose of 
500 mg/kg. bw to diabetic rats induced with streptozotocin 65 
mg/kg. bw. The investigation lasted for eight weeks, and the 
parameters obtained from the study show that M. pudica tend to 
have hypoglycemic properties on fasting blood glucose level of the 
experimental rats [40]. 
Antimicrobial activity 
The preliminary phytochemical screening of the extracts shows the 
presence of carbohydrates, saponins flavonoids, steroids and tannins. 
The activity was tested against Pseudomonas aeruginosa, Bacillus 
subtilis, Klebsiella pneumonia, Aspergillus flavus and trichophyton at 
various concentration like 50, 100, 200 ug/ml. The potential 
sensitivity of the extracts was obtained against all the microorganisms 
tested [41]. Another study by Chukwu et al. also shows the anti-fungal 
activity of the whole plant of M. pudica which was tested towards 
Aspergillus flavus and Trichophyton rubrum, three different 
concentration of M. pudica25 mg/ml, 50 mg/ml and 100 mg/ml were 
used. Results from this study indicate that ethanolic extracts of M. 
pudica exhibited from being partially active to very active against the 
tested microorganism at all concentration [42-44]. 
CONCLUSION 
This review shows that M. pudica is rich with different bioactive 
compounds that possess several pharmacological properties. M. 
pudica, commonly seen in the wastelands and along roadsides, is an 
ethnomedical plant that may be used in managing various types of 
disease. Different phytoconstituents responsible for the activities 
were isolated. This proves the medicinal importance of the plant. 
Few studies had been done on the stem, roots and flower. Therefore, 
advanced research studies are required to validate the therapeutic 
potential of the roots, stem and flower of M. pudica. 
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